← back to search

Balram Bhargava

Serum Institute of India (India) · IN
Area of research
Infectious Diseases · Surgery
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Coronary Interventions and Diagnostics, and COVID-19 epidemiological studies.
h-index
44
citations
8,754
works
229
NIH funding
—
primary concept
Medicine
email
balrambhargava@yahoo.com

Recent publications

Population-based surveillance for hypertension awareness, treatment, and control in nine districts - India Hypertension Control Initiative, 2018-19.
2025cited by 2position: contributordoi
Impact of Complete Revascularization in the ISCHEMIA Trial
Journal of the American College of Cardiology 2023cited by 44position: middledoi
The India Hypertension Control Initiative-early outcomes in 26 districts across five states of India, 2018-2020.
2023cited by 42position: contributordoi
Survival After Invasive or Conservative Management of Stable Coronary Disease
Circulation 2022cited by 144position: middledoi
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques.
2021cited by 64position: contributordoi
The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research
The Lancet Oncology 2021cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Anupam K. Pathni · Elsevier, Inc.2 papers (2023–2025)— · 2 papers (2023–2025)Prabhdeep Kaur · National Institute of Epidemiology2 papers (2023–2025)Xavier Paolettí · Inserm1 papers (2021–2021)Mark Krailo · University of Southern California1 papers (2021–2021)Satish Gopal · University of North Carolina at Chapel Hill1 papers (2021–2021)— · 1 papers (2021–2021)— · 1 papers (2021–2021)— · 1 papers (2021–2021)— · 1 papers (2021–2021)Tapas Chakma · ICMR-National Institute of Research in Tribal Health1 papers (2025–2025)Amirthammal Gunasekaran · National Institute of Epidemiology1 papers (2025–2025)Preetha Rajaraman · University of Illinois Chicago1 papers (2021–2021)Edward L. Trimble · University of Illinois Chicago1 papers (2021–2021)— · 1 papers (2021–2021)Ruth E. Langley · MRC Clinical Trials Unit at UCL1 papers (2021–2021)Mahesh Parmar · MRC Clinical Trials Unit at UCL1 papers (2021–2021)Chris Frampton · University of Otago1 papers (2021–2021)Arnie Purushotham · Guy's and St Thomas' NHS Foundation Trust1 papers (2021–2021)Girish Chinnaswamy · Max Super Speciality Hospital1 papers (2021–2021)